OrthoPediatrics announced the limited launch and the completion of the first clinical case using the new GIRO Growth Modulation System. The GIRO tether device is indicated for pediatric patients to aid in the correction of angular deformities of long bones and limb length discrepancy. Two configurations of the system are available, the GIRO Screw configuration for deformities in the femur and tibia, humerus, radius and ulna or ankle and the GIRO Post configuration for limb length discrepancy of the femur and tibia. Joe Hauser, President of Trauma and Deformity Correction at OrthoPediatrics, added, “The first clinical case with the GIRO Growth Modulation system represents a milestone for our business as we continue to leverage the technology and expertise of our colleagues at OrthoPediatrics Canada. This system provides our pediatric orthopedic surgeon partners with a new option to treat their patients, we are excited to see this technology improve the care of kids.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KIDS:
- OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
- OrthoPediatrics announces election of George Dyer to board of directors
- OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors
- OrthoPediatrics raises FY23 revenue view to $148M to $151M, consensus $147.32M
- OrthoPediatrics reports Q1 EPS (29c), consensus (36c)